tiprankstipranks
Trending News
More News >
Grifols SA (GRFS)
NASDAQ:GRFS
US Market
Advertisement

Grifols SA (GRFS) Earnings Dates, Call Summary & Reports

Compare
452 Followers

Earnings Data

Report Date
Nov 06, 2025
Before Open (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.24
Last Year’s EPS
0.08
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 29, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
Grifols delivered a strong financial performance in the first half of 2025 with significant revenue and EBITDA growth, successful pipeline execution, and a reinstated dividend, despite challenges in foreign exchange volatility and pricing pressures in the Chinese market.
Company Guidance
During Grifols' fiscal year 2025 Q2 call, the company reported a strong set of results, with key financial metrics showcasing significant growth. Revenue for the first half of 2025 reached EUR 3.7 billion, marking a 7% increase on a reported basis and 10.1% like-for-like at constant currency. Adjusted EBITDA rose to EUR 876 million, reflecting a 12.7% increase on a reported basis and 20.1% like-for-like. The company achieved a leverage ratio of 4.2x, and free cash flow improved by nearly EUR 200 million year-over-year. Grifols also announced the reinstatement of dividend payments, with an interim dividend of EUR 0.15 per share. The biopharma segment drove growth, particularly through the immunoglobulin franchise, which grew by 17.8% like-for-like. Despite challenges like foreign exchange volatility and pricing pressure in the albumin market, Grifols remains confident in achieving its full-year guidance, backed by strategic efforts in cost reduction, operational efficiencies, and innovation, such as the upcoming launch of fibrinogen in Europe and the U.S.
Strong Revenue Growth
Grifols achieved revenue of EUR 3.7 billion in the first half of 2025, representing a year-over-year increase of 7% on a reported basis and 10.1% like-for-like at constant currency.
Adjusted EBITDA Increase
Adjusted EBITDA reached EUR 876 million, a 12.7% increase on a reported basis and 20.1% like-for-like at constant currency.
Dividend Reinstatement
Grifols announced a EUR 0.15 per share interim dividend, reinstating dividend payments after over 4 years, reflecting strong financial performance and confidence in future prospects.
Biopharma Segment Growth
Biopharma segment reported 8.2% growth, driven by a 12.5% increase in the IG franchise at constant currency, showcasing strong market demand.
Pipeline Advancements
Significant progress in the innovation pipeline, including the upcoming launch of fibrinogen in Europe (Q4 2025) and the US (first half of 2026).

Grifols SA (GRFS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

GRFS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 06, 2025
2025 (Q3)
0.24 / -
0.084
Jul 29, 2025
2025 (Q2)
0.23 / 0.20
0.024712.50% (+0.17)
May 12, 2025
2025 (Q1)
0.15 / 0.09
0.034170.59% (+0.06)
Feb 26, 2025
2024 (Q4)
0.23 / 0.11
0.08921.35% (+0.02)
Nov 07, 2024
2024 (Q3)
0.22 / 0.08
0.15-44.00% (-0.07)
Jul 30, 2024
2024 (Q2)
0.15 / 0.02
0.165-85.45% (-0.14)
May 14, 2024
2024 (Q1)
0.11 / 0.03
0.044-22.73% (>-0.01)
Feb 29, 2024
2023 (Q4)
0.22 / 0.09
0.1-11.00% (-0.01)
Nov 02, 2023
2023 (Q3)
0.20 / 0.15
0.213-29.58% (-0.06)
Jul 27, 2023
2023 (Q2)
0.20 / 0.17
0.13225.00% (+0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

GRFS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 29, 2025
$9.96$10.36+4.02%
May 12, 2025
$7.00$7.63+9.00%
Feb 26, 2025
$7.28$7.83+7.55%
Nov 07, 2024
$8.93$9.37+4.93%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Grifols SA (GRFS) report earnings?
Grifols SA (GRFS) is schdueled to report earning on Nov 06, 2025, Before Open (Confirmed).
    What is Grifols SA (GRFS) earnings time?
    Grifols SA (GRFS) earnings time is at Nov 06, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is GRFS EPS forecast?
          GRFS EPS forecast for the fiscal quarter 2025 (Q3) is 0.24.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis